Magnaspartate 243 mg powder for oral solution

*
Pharmacy Only: Prescription
  • Company:

    Kora Healthcare
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may be renewed (B)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Updated on 15 August 2022

File name

Magnaspartate-spc.pdf

Reasons for updating

  • Change to MA holder contact details

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 15 August 2022

File name

Magnaspartate-PIL.pdf

Reasons for updating

  • Change to MA holder contact details

Updated on 31 January 2022

File name

SPC-Magnaspartate-Licence_PA1748-002-001.pdf

Reasons for updating

  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to Section 4.8 – Undesirable effects - how to report a side effect

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 31 January 2022

File name

PIL-Magnaspartate-Licence_PA1748-002-001.pdf

Reasons for updating

  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children and adolescents
  • Change to section 4 - how to report a side effect

Updated on 22 July 2020

File name

ie-spc-revised July 2020.pdf

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 6.3 - Shelf life
  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 22 July 2020

File name

ie-pl-revised July 2020.pdf

Reasons for updating

  • Change to section 3 - how to take/use
  • Change to section 5 - how to store or dispose
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Updated on 30 April 2020

File name

ie-spc-revised April 2020.pdf

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 30 April 2020

File name

ie-pl-revised March 2020.pdf

Reasons for updating

  • Change to section 2 - excipient warnings
  • Change to section 5 - how to store or dispose
  • Change to section 6 - date of revision
  • Change of trade or active ingredient name

Updated on 29 April 2019

File name

ie-PIL.pdf

Reasons for updating

  • New PIL for new product

Updated on 29 April 2019

File name

ie-spc.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may be renewed (B)